Cite

HARVARD Citation

    Ionescu, A. et al. (2018). Bedaquiline- versus injectable-containing drug-resistant tuberculosis regimens: a cost-effectiveness analysis. Expert review of pharmacoeconomics & outcomes research. pp. 677-689. [Online]. 
  
Back to record